Tags

Type your tag names separated by a space and hit enter

Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
Clin Infect Dis 2003; 36(2):183-7CI

Abstract

In vitro surveillance data from across the United States indicate that approximately 10%-20% of urinary Escherichia coli isolates from female outpatients are resistant to trimethoprim-sulfamethoxazole (TMP-SMX). Alternative therapies for uncomplicated urinary tract infections in women include fluoroquinolones and nitrofurantoin, but the activities of these agents against TMP-SMX-resistant isolates are rarely reported. Among TMP-SMX-resistant urinary E. coli isolates tested in US laboratories from 1998 through 2001, 9.5% (5767 of 60,414) were resistant to ciprofloxacin and 1.9% (1214 of 63,817) were resistant to nitrofurantoin; 10.4% of ciprofloxacin-resistant isolates (683 of 6560) were resistant to nitrofurantoin. An association between resistance to fluoroquinolones and nitrofurantoin in E. coli has not been previously reported and warrants further study.

Authors+Show Affiliations

Focus Technologies, Herndon, Virginia 20171-4603, USA. jkarlowsky@focusanswers.comNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

12522750

Citation

Karlowsky, James A., et al. "Susceptibility of Antimicrobial-resistant Urinary Escherichia Coli Isolates to Fluoroquinolones and Nitrofurantoin." Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, vol. 36, no. 2, 2003, pp. 183-7.
Karlowsky JA, Thornsberry C, Jones ME, et al. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin. Clin Infect Dis. 2003;36(2):183-7.
Karlowsky, J. A., Thornsberry, C., Jones, M. E., & Sahm, D. F. (2003). Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, 36(2), pp. 183-7.
Karlowsky JA, et al. Susceptibility of Antimicrobial-resistant Urinary Escherichia Coli Isolates to Fluoroquinolones and Nitrofurantoin. Clin Infect Dis. 2003 Jan 15;36(2):183-7. PubMed PMID: 12522750.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin. AU - Karlowsky,James A, AU - Thornsberry,Clyde, AU - Jones,Mark E, AU - Sahm,Daniel F, Y1 - 2003/01/03/ PY - 2002/06/12/received PY - 2002/10/14/accepted PY - 2003/1/11/pubmed PY - 2003/2/6/medline PY - 2003/1/11/entrez SP - 183 EP - 7 JF - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America JO - Clin. Infect. Dis. VL - 36 IS - 2 N2 - In vitro surveillance data from across the United States indicate that approximately 10%-20% of urinary Escherichia coli isolates from female outpatients are resistant to trimethoprim-sulfamethoxazole (TMP-SMX). Alternative therapies for uncomplicated urinary tract infections in women include fluoroquinolones and nitrofurantoin, but the activities of these agents against TMP-SMX-resistant isolates are rarely reported. Among TMP-SMX-resistant urinary E. coli isolates tested in US laboratories from 1998 through 2001, 9.5% (5767 of 60,414) were resistant to ciprofloxacin and 1.9% (1214 of 63,817) were resistant to nitrofurantoin; 10.4% of ciprofloxacin-resistant isolates (683 of 6560) were resistant to nitrofurantoin. An association between resistance to fluoroquinolones and nitrofurantoin in E. coli has not been previously reported and warrants further study. SN - 1537-6591 UR - https://www.unboundmedicine.com/medline/citation/12522750/full_citation L2 - https://academic.oup.com/cid/article-lookup/doi/10.1086/345754 DB - PRIME DP - Unbound Medicine ER -